EVENTS · JNJ
PEERS
EARNINGS
Johnson & Johnson is a global healthcare company that develops, manufactures, and markets a broad range of products across pharmaceuticals and medical technology. Its Innovative Medicine segment focuses on therapies in areas such as immunology, infectious diseases, neuroscience, oncology, and cardiovascular care, while its MedTech segment provides medical devices and solutions used in surgery, orthopedics, interventional procedures, and vision care. The company serves hospitals, clinicians, patients, and healthcare systems in markets around the world, making it a central participant in both drug development and medical device supply chains. Johnson & Johnson is known for operating at the intersection of large-scale research, clinical innovation, and essential healthcare delivery, with products that support prevention, treatment, diagnosis, and recovery across a wide range of medical settings.
Drug makers broadly rallied after Amgen and Novo Nordisk raised their full-year forecasts on strong results, lifting the whole group including Johnson and Johnson
| Series | 1W | 1M |
|---|---|---|
| JNJ | +2.0% | +8.5% |
| Peers | +7.1% | +14.2% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 35 | 50 |
| QUARTER | EPS EST | EPS ACTUAL | EPS SURPRISE | REACTION |
|---|---|---|---|---|
| Q3 FY2026 | 2.53 | 0.09 | −96.44% | −3.72% |
| Q2 FY2026 | 2.87 | 2.90 | +0.89% | — |
| Q1 FY2026 | 2.69 | 2.70 | +0.32% | — |
| Q4 FY2025 | 2.46 | 2.46 | −0.13% | — |
| Q3 FY2025 | — | 2.12 | — | +0.14% |
| Series | 1W | 1M |
|---|---|---|
| JNJ | +2.0% | +8.5% |
| Peers | +7.1% | +14.2% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 35 | 50 |
